News
In the fourth quarter of 2025, Black Diamond expects to disclose objective response rate (ORR) and preliminary duration of response (DOR) data from all patients (n=43) in the Phase 2 trial of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback